Mindfulness-Based Intervention for Cardiovascular Health in Older Adults with HIV
(OM-OH Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your healthcare provider.
What data supports the effectiveness of the treatment One Mind One Heart (OM-OH) for cardiovascular health in older adults with HIV?
Research shows that mindfulness-based interventions, like the One Mind One Heart treatment, can help reduce stress and improve emotional well-being in people living with HIV. Additionally, yoga, a component of mindfulness practices, has been shown to lower blood pressure in HIV-infected adults with cardiovascular risk factors.12345
Is mindfulness-based intervention safe for people with HIV?
How is the One Mind One Heart treatment different from other treatments for cardiovascular health in older adults with HIV?
The One Mind One Heart treatment is unique because it focuses on mindfulness-based interventions, which aim to reduce stress and improve emotional well-being, potentially benefiting cardiovascular health. Unlike standard medical treatments, this approach emphasizes mental and emotional health as a way to support physical health in people living with HIV.12348
What is the purpose of this trial?
This trial tests a new program called 'One Mind One Heart' (OM-OH) that uses mindfulness and behavior change techniques sent via text messages. It aims to help older people with HIV who are stressed and at risk for heart disease. The program hopes to reduce stress and inflammation, improving heart health.
Eligibility Criteria
This trial is for people over 50 with HIV who have controlled viral loads and are experiencing psychological distress. They must also have at least one risk factor for heart disease, like diabetes or high blood pressure, and be able to receive text messages on their cell phone.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Open Pilot
An open pilot with exit interviews and pre-post self-report assessments to inform the initial acceptability of OM-OH
Pilot Randomized Controlled Trial (RCT)
A pilot RCT to evaluate feasibility and acceptability of OM-OH compared to enhanced usual care
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- One Mind One Heart
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator